Overview

Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The aim of the study was to evaluate the efficacy and safety of BF-200 ALA (Ameluz) used with photodynamic therapy (PDT) in patients suffering from actinic keratosis.
Phase:
Phase 3
Details
Lead Sponsor:
Biofrontera Bioscience GmbH
Treatments:
Aminolevulinic Acid